RE:warrants crashed and burned today Doubtfully, not to say impossible, unless a disaster on the clinical data side.
The FDA designation alone, due this year, would bring us much higher than 0.43$.
I go with BlueFranky's potential explanation. It makes more sense, given what lies ahead. Think of it for a second; we're being valued at 40M$US, the equivalent of a Serie A financing (so for something unproven, still in lab, with no human data)! All this, while we are 50% into a pivotal Ph. 2, with CR @90-days of approx. 60%+, DR @450-days of approx. 30%, higher than competition, with no SAE, no toxicity to patients and only 2 treatments.
It's hard for many here to believe that this stock price will move higher because of the past but on Jan. 3rd, TLT management decided that it was now ready to move higher, go on the offensive, take steps toward commercialization, with all the actions announced in that Jan. 3rd article, the ASCO-GU and AUA presence, this AUA booth, the FDA designation, these upcoming 2023-2924 discussions with big pharmas, etc ....
TLT, just like any other biotechs at one time in its existence, is moving to another level. And it will be reflected in the market valuation over time throughout 2023-2024 period and more.
TMX-V days should logically leave room for higher exchanges if we plan to expand our other indications.
__________________
riverrrow - (4/25/2023 5:27:53 PM)
warrants crashed and burned today
A ton of warrants sold today at 8 cents or less. That means somebody doesn't think TLT will break 43 cents between now and August 2024. And here I was dreaming TLT will be above $3 by then. GLTA.